...
首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis of 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides and their evaluation as ligands for NMDA receptor glycine binding site
【24h】

Synthesis of 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides and their evaluation as ligands for NMDA receptor glycine binding site

机译:合成3,4-二氢-2H-1,2-苯并噻嗪-3-羧酸1,1-二氧化氧化物及其作为NMDA受体甘氨酸甘氨酸甘氨酸结合位点的配体的评价

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 2-substituted 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides were synthesized and evaluated for their affinity to the glycine binding site of the N-methyl-D-aspartate (NMDA) receptor. The binding affinity was determined by the displacement of radioligand [H-3]MDL-105,519 from rat cortical membrane preparations. The most attractive structures in the search for prospective NMDA receptor ligands were identified to be 2-arylcarbonylmethyl substituted 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides. It has been demonstrated for the first time that the replacement of NH group in the ligand by sp(3) CH2 is tolerated. This finding may pave the way for previously unexplored approaches for designing new ligands of the NMDA receptor.
机译:合成了一系列2取代的3,4-二氢-2H-1,2-苯并噻嗪-3-羧酸1,1-二氧化氧化物,并评价其对N-甲基-D-天冬氨酸的甘氨酸结合位点的亲和力 (NMDA)受体。 通过来自大鼠皮质膜制剂的放射性配体[H-3] MDL-10519的位移来确定结合亲和力。 在寻找前瞻性NMDA受体配体中最具吸引力的结构被鉴定为2-芳基羰基甲基取代的3,4-二氢-2H-1,2-苯并噻嗪-3-羧酸1,1-二氧化氧化物。 首次证明了SP(3)CH2在配体中替换NH组的第一次进行耐受。 这一发现可以为以前未开发的核磁共振传染性的新配体铺平以前未开发的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号